Don't miss this GROUNDBREAKING discussion on recent publications in the British Medical Journal
| |
WEBINAR - APRIL 19
Discover the Future of IPM with AI
Please join us on April 19th for ASIPP’s exclusive webinar:
Automation Through Artificial Intelligence in IPM
Learn how AI-powered tools are transforming documentation, communication, patient engagement, revenue cycle management, procedure training, and more.
| | |
The US Food and Drug Administration (FDA) has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, Bristol Myers Squibb) for the treatment of adults and children aged 12 years and older with certain types of colorectal cancer (CRC).
Specifically, the combination is approved for those with metastatic microsatellite-high (MSI-H) or mismatch repair deficient (dMMR) CRC, adding to the list of other indications for the combination therapy.
The FDA also converted the previously accelerated approval to regular approval for single-agent nivolumab for adults and children aged 12 years and older with MSI-H and dMMR CRC whose disease progressed following treatment with fluoropyrimidine, oxaliplatin, and irinotecan, according to the FDA approval notice.
Read More
| |
|
Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve claims by U.S. state and local governments that it fueled an epidemic of opioid addiction.
The Pennsylvania-based company, formed by the merger of Mylan and Pfizer's Upjohn business in 2020, did not admit wrongdoing as part of the agreement. It said it would pay between $27.5 million and $40 million annually toward state and local opioid initiatives as part of the settlement.
"When drug companies put profits over people, innocent patients can get sucked into deadly cycles of addiction and overdoses," New York Attorney General Letitia James, one of the leaders in negotiating the settlement, said in a statement. "While no settlement can fully repair the damage caused by dangerous opioids, these funds will help New York and other states fight the opioid crisis."
Read More
| | |
New 2025 Dates
Mark your calendars!
April 26, May 31, & June 28
Four (4) hour virtual exam
- ABIPP Path – Combined CCPM/ CSM Exam
For those with subspecialty in Pain Medicine
Two (2) hour virtual exam
- ABIPP Competency Exam in IPM
For those without primary board certification
Two (2) hour virtual exam
- ABIPP Competency Exam in Regenerative Medicine
Two (2) hour virtual exam
- Controlled Substance Management Competency Exam
Two (2) hour virtual exam
- Documentation, Coding, Compliance, Practice Management Competency Exam
Two (2) hour virtual exam
| | |
Working in certain professions — religion, medicine, and the law come to mind — is more likely to be associated with the idea of a calling than others. (We don’t commonly think of plumbers, office managers, or salespeople as being “called” to their work.) But while definitions of a “calling” vary, authors of a recent survey of more than 1200 physicians and advanced care providers defined a calling as “a commitment to work that is personally meaningful and serves a prosocial purpose.”
The survey, conducted by Jackson Physician Search and Locum Tenens, found that 90% of physicians described medicine as a calling at the onset of their careers. Half found that sense of calling weakened over time.
Did you still feel “called” to practice medicine?
Read More
| | - ASIPP Members Only Site Information - | |
-
To log in for the first time you will need to click “forgot password” at the bottom of the login window.
- Check your email and then log in as directed.
-
If you have problems logging into your account, click here.
| | |
Key takeaways:
- Tax loss harvesting involves selling underperforming investments to offset capital gains taxes on profitable investments.
- Consider contributing to a Backdoor Roth IRA for you and your spouse for tax-free growth and withdrawals in retirement.
With tax season here, physicians juggling hectic clinical schedules must also focus on optimizing their financial strategies. With proper planning, physicians can take advantage of key tax-saving opportunities to maximize their wealth.
Click here to read a few crucial tax tips to help physicians navigate tax season efficiently and effectively.
| |
|
For decades, the placebo effect — the phenomenon where a patient’s condition improves after receiving an inert treatment, often a sugar pill, because they believe it to be real medication — has fascinated and sometimes confounded the medical community. But what happens when you remove the deception and tell patients outright that they are receiving a placebo?
A lot, it turns out.
For a long time, scientists assumed telling patients they were getting a placebo would reduce the effect because the patients wouldn’t think they could be getting the actual treatment in a randomized trial. Surprisingly, a growing body of research suggests that these “open-label placebos” can still lead to positive health outcomes, and many past studies of open-label placebos give patients an explanation of why they might work.
Read More
| | |
Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.
Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.
Interested in becoming a member of the PMCR Editorial Board?
Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.
For more information or to submit your articles, click here.
| | |
We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.
The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.
The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.
We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.
| | | | |
|
Alvise Martini, MD, Vittorio Schweiger, MD, Libera Villagrossi, MD, Alex Patton, MD, Giuseppina Poni, MD, and Enrico Polati, MD
| | |
Neha Singh, MD, Loc Lam, DO, and Emanuel Narcis Husu, MD
| | | | |
Chiao-Ming Chuang, MD, Chung-Ren Lin, MD, PhD, and Yu-Lien Hsieh, MD
| |
Mihir Jani, MD, Eli Dayon, DO, Nimesha Mehta, DO, Kunal Aggarwal, MD, Joseph D. Fortin, DO, Karoline Zektser, DO, Joshua Lewis, MD, PhD, Marco Lawandy, DO, Ricky Ju, DO, Ugur Yener, MD, Jonathan D. Krystal, MD, Reza Yassari, MD, Alan D. Kaye, MD, PhD, and Sayed E. Wahezi, MD
| |
Weiming Luo, MD, Yuke Teng, MD, Xingyao Chen, MM, Nuo Chen, MD, Xinyue Zhang, MD, Jun Zhou, MD, Siyuan Tao, MD, Peng Lai, MD, Qian Song, PhD, Xinyu Hao, PhD, Fanrong Liang, PhD, Zhaoxuan He, PhD, and Zhengjie Li, MD
| | | | |
|
ASIPP is now in collaboration with Curi Medical Liability Program
Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices.
Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.
| | |
|
Group Purchasing Organization Offer Better Pricing and Creates Added Value
ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.
Learn More
| | |
|
ASIPP, Fedora Healthcare Solutions Partnership
ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.
We have received a tremendous amount of interest in the ASIPP billing and coding program.
Click here to learn more about the negotiated rate for practices and more!
| | Like and follow ASIPP® on Facebook, X, LinkedIn, and YouTube for the most up-to-date news related to you, your practice, and your patients! | | | | |